Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Beam Therapeutics Inc.
IPO Date: February 6, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.67B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.59 | 3.49%
Avg Daily Range (30 D): $0.37 | 2.14%
Avg Daily Range (90 D): $0.81 | 3.75%
Institutional Daily Volume
Avg Daily Volume: .88M
Avg Daily Volume (30 D): 1.59M
Avg Daily Volume (90 D): 1.9M
Trade Size
Avg Trade Size (Sh.): 58
Avg Trade Size (Sh.) (30 D): 64
Avg Trade Size (Sh.) (90 D): 69
Institutional Trades
Total Inst.Trades: 2,950
Avg Inst. Trade: $3.15M
Avg Inst. Trade (30 D): $2.57M
Avg Inst. Trade (90 D): $2.91M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.86M
Avg Closing Trade (30 D): $3.76M
Avg Closing Trade (90 D): $5.09M
Avg Closing Volume: 131.2K
   
News
Jun 17, 2025 @ 2:07 PM
Editas Medicine Is Great. Here's Why You Shouldn't...
Source: Dan Victor
May 29, 2025 @ 8:01 PM
Beam Therapeutics Announces U.S. FDA Orphan Drug D...
Source: N/A
May 6, 2025 @ 9:05 PM
Why Beam Therapeutics Stock Tanked on Tuesday
Source: Eric Volkman
Mar 10, 2025 @ 10:01 AM
Beam Therapeutics Announces Pricing of Underwritte...
Source: N/A
Feb 24, 2025 @ 12:00 PM
Beam Therapeutics to Participate in Upcoming March...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-4.61 $-1.24 $-1.09
Diluted EPS $-4.61 $-1.24 $-1.09
Revenue $ 63.58M $ 7.47M $ 30.07M
Gross Profit $ $ $
Net Income / Loss $ -387.34M $ -109.27M $ -90.35M
Operating Income / Loss $ -430.72M $ -119.29M $ -100.04M
Cost of Revenue $ $ $
Net Cash Flow $ 240.22M $ 244.41M $ 53.36M
PE Ratio